Detalhe da pesquisa
1.
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol.
Circulation
; 143(25): 2431-2440, 2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993702
2.
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.
Eur Heart J
; 37(21): 1671-80, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26903532
3.
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction.
JACC CardioOncol
; 6(1): 83-95, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510299
4.
[Cardioprotective treatment during adjuvant cancer therapy]. / Kardioprotektiv behandling ved adjuvant kreftterapi.
Tidsskr Nor Laegeforen
; 133(17): 1832-6, 2013 Sep 17.
Artigo
em Norueguês
| MEDLINE | ID: mdl-24042297
5.
Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial.
Cardiology
; 123(4): 240-7, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23207160
6.
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review.
JACC CardioOncol
; 4(1): 19-37, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35492815
7.
Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial.
Eur Heart J Cardiovasc Imaging
; 19(5): 544-552, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29106497
8.
Accuracy and complications in computed tomography fluoroscopy-guided needle biopsies of lung masses.
Eur Radiol
; 16(6): 1387-92, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16541227